ResMed Statistics

Total Valuation

ResMed has a market cap or net worth of EUR 32.50 billion. The enterprise value is 32.41 billion.

Market Cap	32.50B
Enterprise Value	32.41B

Important Dates

The next estimated earnings date is Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	146.63M
Shares Outstanding	n/a
Shares Change (YoY)	-0.07%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	145.69M

Valuation Ratios

The trailing PE ratio is 26.75 and the forward PE ratio is 24.27.

PE Ratio	26.75
Forward PE	24.27
PS Ratio	7.00
PB Ratio	6.33
P/TBV Ratio	15.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.96, with an EV/FCF ratio of 22.33.

EV / Earnings	26.67
EV / Sales	7.21
EV / EBITDA	19.96
EV / EBIT	22.42
EV / FCF	22.33

Financial Position

The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.15.

Current Ratio	3.41
Quick Ratio	2.06
Debt / Equity	0.15
Debt / EBITDA	0.46
Debt / FCF	0.54
Interest Coverage	139.28

Financial Efficiency

Return on equity (ROE) is 25.81% and return on invested capital (ROIC) is 16.54%.

Return on Equity (ROE)	25.81%
Return on Assets (ROA)	14.01%
Return on Invested Capital (ROIC)	16.54%
Return on Capital Employed (ROCE)	24.33%
Revenue Per Employee	465,523
Profits Per Employee	121,746
Employee Count	9,980
Asset Turnover	0.70
Inventory Turnover	2.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+8.27%
50-Day Moving Average	203.10
200-Day Moving Average	216.74
Relative Strength Index (RSI)	66.90
Average Volume (20 Days)	36

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	8.76

Income Statement

In the last 12 months, ResMed had revenue of EUR 4.65 billion and earned 1.22 billion in profits. Earnings per share was 8.24.

Revenue	4.65B
Gross Profit	2.76B
Operating Income	1.49B
Pretax Income	1.46B
Net Income	1.22B
EBITDA	1.63B
EBIT	1.49B
Earnings Per Share (EPS)	8.24

Full Income Statement

Balance Sheet

The company has 874.17 million in cash and 776.96 million in debt, giving a net cash position of 97.21 million.

Cash & Cash Equivalents	874.17M
Total Debt	776.96M
Net Cash	97.21M
Net Cash Per Share	n/a
Equity (Book Value)	5.13B
Book Value Per Share	35.00
Working Capital	2.10B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.53 billion and capital expenditures -77.87 million, giving a free cash flow of 1.45 billion.

Operating Cash Flow	1.53B
Capital Expenditures	-77.87M
Free Cash Flow	1.45B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.37%, with operating and profit margins of 32.10% and 26.15%.

Gross Margin	59.37%
Operating Margin	32.10%
Pretax Margin	31.41%
Profit Margin	26.15%
EBITDA Margin	35.14%
EBIT Margin	32.10%
FCF Margin	31.24%

Dividends & Yields

This stock pays an annual dividend of 1.95, which amounts to a dividend yield of 0.91%.

Dividend Per Share	1.95
Dividend Yield	0.91%
Dividend Growth (YoY)	9.71%
Years of Dividend Growth	3
Payout Ratio	23.14%
Buyback Yield	0.07%
Shareholder Yield	0.98%
Earnings Yield	3.74%
FCF Yield	4.47%

Dividend Details

Stock Splits

The last stock split was on August 31, 2010. It was a forward split with a ratio of 2.

Last Split Date	Aug 31, 2010
Split Type	Forward
Split Ratio	2

Scores

ResMed has an Altman Z-Score of 12.61.

Altman Z-Score	12.61
Piotroski F-Score	n/a